| C1J | Name: | N~5~-(N-octylcarbamimidoyl)-L-ornithine | Formula: | C14 H30 N4 O2 | SMILES: | NC(C(O)=O)CCCN/C(NCCCCCCCC)=N | InChi: | InChI=1S/C14H30N4O2/c1-2-3-4-5-6-7-10-17-14(16)18-11-8-9-12(15)13(19)20/h12H,2-11,15H2,1H3,(H,19,20)(H3,16,17,18)/t12-/m0/s1 | Definition date: | 2017-09-08 | Last modified: | 2023-11-03 | Release date: | 2017-12-13 | Identifier: | N~5~-(N-octylcarbamimidoyl)-L-ornithine |
|
| C1X | Name: | (Z)-N~6~-[(4R,5S)-5-(2-CARBOXYETHYL)-4-(CARBOXYMETHYL)DIHYDRO-2H-THIOPYRAN-3(4H)-YLIDENE]-L-LYSINE | Formula: | C16 H26 N2 O6 S | SMILES: | O=C(O)C(N)CCCC/N=C1/CSCC(CCC(=O)O)C1CC(=O)O | InChi: | InChI=1S/C16H26N2O6S/c17-12(16(23)24)3-1-2-6-18-13-9-25-8-10(4-5-14(19)20)11(13)7-15(21)22/h10-12H,1-9,17H2,(H,19,20)(H,21,22)(H,23,24)/b18-13-/t10-,11-,12+/m1/s1 | Synonyms: | 2-AMINO-6-[5-(2-CARBOXY-ETHYL)-4-CARBOXYMETHYL-DIHYDRO-THIOPYRAN-3-YLIDENEAMINO]-HEXANOIC ACID | Definition date: | 2005-09-11 | Last modified: | 2023-11-03 | Identifier: | (E)-N~6~-[(4R,5S)-5-(2-carboxyethyl)-4-(carboxymethyl)dihydro-2H-thiopyran-3(4H)-ylidene]-L-lysine |
|
| 81R | Name: | (4R)-4,5-disulfanyl-L-norvaline | Formula: | C5 H11 N O2 S2 | SMILES: | O=C(O)C(N)CC(S)CS | InChi: | InChI=1S/C5H11NO2S2/c6-4(5(7)8)1-3(10)2-9/h3-4,9-10H,1-2,6H2,(H,7,8)/t3-,4+/m1/s1 | Definition date: | 2014-02-19 | Last modified: | 2023-11-03 | Release date: | 2014-09-24 | Identifier: | (4R)-4,5-disulfanyl-L-norvaline |
|
| 81S | Name: | (4S)-4,5-disulfanyl-L-norvaline | Formula: | C5 H11 N O2 S2 | SMILES: | O=C(O)C(N)CC(S)CS | InChi: | InChI=1S/C5H11NO2S2/c6-4(5(7)8)1-3(10)2-9/h3-4,9-10H,1-2,6H2,(H,7,8)/t3-,4-/m0/s1 | Definition date: | 2014-02-19 | Last modified: | 2023-11-03 | Release date: | 2014-09-24 | Identifier: | (4S)-4,5-disulfanyl-L-norvaline |
|
| 823 | Name: | N,N-bis(3-sulfanylpropyl)-L-asparagine | Formula: | C10 H20 N2 O3 S2 | SMILES: | O=C(O)C(N)CC(=O)N(CCCS)CCCS | InChi: | InChI=1S/C10H20N2O3S2/c11-8(10(14)15)7-9(13)12(3-1-5-16)4-2-6-17/h8,16-17H,1-7,11H2,(H,14,15)/t8-/m0/s1 | Definition date: | 2014-02-19 | Last modified: | 2023-11-03 | Release date: | 2014-09-24 | Identifier: | N,N-bis(3-sulfanylpropyl)-L-asparagine |
|
| JG3 | Name: | 1-[(2S,3S)-3-amino-2-hydroxy-4-phenylbutyl]-L-proline | Formula: | C15 H22 N2 O3 | SMILES: | O=C(O)C2N(CC(O)C(N)Cc1ccccc1)CCC2 | InChi: | InChI=1S/C15H22N2O3/c16-12(9-11-5-2-1-3-6-11)14(18)10-17-8-4-7-13(17)15(19)20/h1-3,5-6,12-14,18H,4,7-10,16H2,(H,19,20)/t12-,13-,14-/m0/s1 | Definition date: | 2010-09-13 | Last modified: | 2023-11-03 | Identifier: | 1-[(2S,3S)-3-amino-2-hydroxy-4-phenylbutyl]-L-proline |
|
| 85G | Name: | N-ethyl-L-glutamine | Formula: | C7 H14 N2 O3 | SMILES: | NC(C(O)=O)CCC(NCC)=O | InChi: | InChI=1S/C7H14N2O3/c1-2-9-6(10)4-3-5(8)7(11)12/h5H,2-4,8H2,1H3,(H,9,10)(H,11,12)/t5-/m0/s1 | Definition date: | 2017-01-05 | Last modified: | 2023-11-03 | Release date: | 2017-05-24 | Identifier: | N-ethyl-L-glutamine |
|
| 85J | Name: | N-propyl-L-glutamine | Formula: | C8 H16 N2 O3 | SMILES: | NC(CCC(NCCC)=O)C(O)=O | InChi: | InChI=1S/C8H16N2O3/c1-2-5-10-7(11)4-3-6(9)8(12)13/h6H,2-5,9H2,1H3,(H,10,11)(H,12,13)/t6-/m0/s1 | Definition date: | 2017-01-05 | Last modified: | 2023-11-03 | Release date: | 2017-05-24 | Identifier: | N-propyl-L-glutamine |
|
| JKH | Name: | 4-amino-Proline | Formula: | C5 H11 N2 O2 | SMILES: | [NH3+][CH]1CN[CH](C1)C(O)=O | InChi: | InChI=1S/C5H10N2O2/c6-3-1-4(5(8)9)7-2-3/h3-4,7H,1-2,6H2,(H,8,9)/p+1/t3-,4-/m0/s1 | Definition date: | 2019-03-07 | Last modified: | 2023-11-03 | Release date: | 2019-05-29 | Identifier: | [(3~{S},5~{S})-5-carboxypyrrolidin-3-yl]azanium |
|
| JLP | Name: | (2S)-2-azanyl-6-[E-[5-(hydroxymethyl)-2-methyl-3-oxidanyl-pyridin-4-yl]methylideneamino]hexanoic acid | Formula: | C14 H21 N3 O4 | SMILES: | Cc1ncc(CO)c(C=NCCCC[CH](N)C(O)=O)c1O | InChi: | InChI=1S/C14H21N3O4/c1-9-13(19)11(10(8-18)6-17-9)7-16-5-3-2-4-12(15)14(20)21/h6-7,12,18-19H,2-5,8,15H2,1H3,(H,20,21)/b16-7+/t12-/m0/s1 | Definition date: | 2018-06-03 | Last modified: | 2023-11-03 | Release date: | 2019-05-29 | Identifier: | (2~{S})-2-azanyl-6-[(~{E})-[5-(hydroxymethyl)-2-methyl-3-oxidanyl-pyridin-4-yl]methylideneamino]hexanoic acid |
|
| JMO | Name: | (2R)-4-cyano-2-[(2~{S})-2-(methylamino)propanoyl]oxy-butanoic acid | Formula: | C9 H14 N2 O4 | SMILES: | CN[CH](C)C(=O)O[CH](CCC#N)C(O)=O | InChi: | InChI=1S/C9H14N2O4/c1-6(11-2)9(14)15-7(8(12)13)4-3-5-10/h6-7,11H,3-4H2,1-2H3,(H,12,13)/t6-,7+/m0/s1 | Definition date: | 2022-05-05 | Last modified: | 2023-11-03 | Release date: | 2023-03-22 | Identifier: | (2~{R})-4-cyano-2-[(2~{S})-2-(methylamino)propanoyl]oxy-butanoic acid |
|
| JMX | Name: | (2S)-3-[1-[(4-bromophenyl)methyl]indol-3-yl]-2-(methylamino)propanoic acid | Formula: | C19 H19 Br N2 O2 | SMILES: | CN[CH](Cc1cn(Cc2ccc(Br)cc2)c3ccccc13)C(O)=O | InChi: | InChI=1S/C19H19BrN2O2/c1-21-17(19(23)24)10-14-12-22(18-5-3-2-4-16(14)18)11-13-6-8-15(20)9-7-13/h2-9,12,17,21H,10-11H2,1H3,(H,23,24)/t17-/m0/s1 | Synonyms: | SC45647 | Definition date: | 2022-05-05 | Last modified: | 2023-11-03 | Release date: | 2023-03-22 | Identifier: | (2~{S})-3-[1-[(4-bromophenyl)methyl]indol-3-yl]-2-(methylamino)propanoic acid |
|
| 8BB | Name: | trans-4-{[(E)-1-amino-2-sulfanylethenyl]carbamoyl}cyclohexanecarboxylic acid | Formula: | C10 H16 N2 O3 S | SMILES: | O=C(O)C1CCC(C(=O)NC(=CS)N)CC1 | InChi: | InChI=1S/C10H16N2O3S/c11-8(5-16)12-9(13)6-1-3-7(4-2-6)10(14)15/h5-7,16H,1-4,11H2,(H,12,13)(H,14,15)/b8-5+/t6-,7- | Definition date: | 2012-01-04 | Last modified: | 2023-11-03 | Identifier: | trans-4-{[(E)-1-amino-2-sulfanylethenyl]carbamoyl}cyclohexanecarboxylic acid |
|
| JQ0 | Name: | methyl 2-[(3~{a}~{R},6~{R},8~{a}~{S})-6-(2-methylpropyl)-8-oxidanylidene-1,2,3,3~{a},6,8~{a}-hexahydropyrrolo[2,3-c]azepin-7-yl]ethanoate | Formula: | C15 H24 N2 O3 | SMILES: | COC(=O)CN1[CH](CC(C)C)C=C[CH]2CCN[CH]2C1=O | InChi: | InChI=1S/C15H24N2O3/c1-10(2)8-12-5-4-11-6-7-16-14(11)15(19)17(12)9-13(18)20-3/h4-5,10-12,14,16H,6-9H2,1-3H3/t11-,12-,14-/m0/s1 | Definition date: | 2023-08-08 | Last modified: | 2023-11-03 | Release date: | 2023-08-16 | Identifier: | methyl 2-[(3~{a}~{R},6~{R},8~{a}~{S})-6-(2-methylpropyl)-8-oxidanylidene-1,2,3,3~{a},6,8~{a}-hexahydropyrrolo[2,3-c]azepin-7-yl]ethanoate |
|
| NUR | Name: | 2-(3-chlorophenyl)-N-(isoquinolin-4-yl)-N-methylacetamide | Formula: | C18 H15 Cl N2 O | SMILES: | Clc1cccc(c1)CC(=O)N(C)c1cncc2ccccc21 | InChi: | InChI=1S/C18H15ClN2O/c1-21(18(22)10-13-5-4-7-15(19)9-13)17-12-20-11-14-6-2-3-8-16(14)17/h2-9,11-12H,10H2,1H3 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(isoquinolin-4-yl)-N-methylacetamide |
|
| NV9 | Name: | 2-(3-chlorophenyl)-N-(4-phenylpyridin-3-yl)acetamide | Formula: | C19 H15 Cl N2 O | SMILES: | O=C(Nc1cnccc1c1ccccc1)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C19H15ClN2O/c20-16-8-4-5-14(11-16)12-19(23)22-18-13-21-10-9-17(18)15-6-2-1-3-7-15/h1-11,13H,12H2,(H,22,23) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(4-phenylpyridin-3-yl)acetamide |
|
| NVA | Name: | NORVALINE | Formula: | C5 H11 N O2 | SMILES: | O=C(O)C(N)CCC | InChi: | InChI=1S/C5H11NO2/c1-2-3-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | L-norvaline |
|
| NW0 | Name: | 3-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide | Formula: | C15 H15 Cl N2 O | SMILES: | O=C(Nc1cnccc1C)CCc1cccc(Cl)c1 | InChi: | InChI=1S/C15H15ClN2O/c1-11-7-8-17-10-14(11)18-15(19)6-5-12-3-2-4-13(16)9-12/h2-4,7-10H,5-6H2,1H3,(H,18,19) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 3-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide |
|
| NX9 | Name: | 2-(3-chlorophenyl)-N-(1H-pyrazol-4-yl)acetamide | Formula: | C11 H10 Cl N3 O | SMILES: | O=C(Cc1cccc(Cl)c1)Nc1c[NH]nc1 | InChi: | InChI=1S/C11H10ClN3O/c12-9-3-1-2-8(4-9)5-11(16)15-10-6-13-14-7-10/h1-4,6-7H,5H2,(H,13,14)(H,15,16) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(1H-pyrazol-4-yl)acetamide |
|
| NYB | Name: | N-METHYL-S-[(1R)-1-METHYLPROPYL]-L-CYSTEINE | Formula: | C8 H17 N O2 S | SMILES: | O=C(O)C(NC)CSC(CC)C | InChi: | InChI=1S/C8H17NO2S/c1-4-6(2)12-5-7(9-3)8(10)11/h6-7,9H,4-5H2,1-3H3,(H,10,11)/t6-,7+/m1/s1 | Definition date: | 2010-07-14 | Last modified: | 2023-11-03 | Identifier: | N-methyl-S-[(1R)-1-methylpropyl]-L-cysteine |
|
| NYG | Name: | [(4Z)-2-[(1S)-1,3-DIAMINO-3-OXOPROPYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | Formula: | C15 H16 N4 O5 | SMILES: | O=C(N)CC(N)C1=N/C(C(=O)N1CC(=O)O)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C15H16N4O5/c16-10(6-12(17)21)14-18-11(15(24)19(14)7-13(22)23)5-8-1-3-9(20)4-2-8/h1-5,10,20H,6-7,16H2,(H2,17,21)(H,22,23)/b11-5-/t10-/m0/s1 | Synonyms: | CHROMOPHORE (ASN-TYR-GLY) | Definition date: | 2007-01-19 | Last modified: | 2023-11-03 | Identifier: | {(4Z)-2-[(1S)-1,3-diamino-3-oxopropyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| NYR | Name: | N-(3-chlorophenyl)-2-(3-methyl-1H-pyrazol-4-yl)acetamide | Formula: | C12 H12 Cl N3 O | SMILES: | O=C(Cc1c[NH]nc1C)Nc1cccc(Cl)c1 | InChi: | InChI=1S/C12H12ClN3O/c1-8-9(7-14-16-8)5-12(17)15-11-4-2-3-10(13)6-11/h2-4,6-7H,5H2,1H3,(H,14,16)(H,15,17) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(3-chlorophenyl)-2-(3-methyl-1H-pyrazol-4-yl)acetamide |
|
| NZC | Name: | N-methylidene-L-threonine | Formula: | C5 H11 N O3 | SMILES: | O=C(O)C(NC)C(O)C | InChi: | InChI=1S/C5H11NO3/c1-3(7)4(6-2)5(8)9/h3-4,6-7H,1-2H3,(H,8,9)/t3-,4+/m1/s1 | Definition date: | 2015-02-05 | Last modified: | 2023-11-03 | Release date: | 2015-06-03 | Identifier: | N-methyl-L-threonine |
|
| NZK | Name: | 2-(4-acetylpiperazin-1-yl)-N-(isoquinolin-4-yl)acetamide | Formula: | C17 H20 N4 O2 | SMILES: | O=C(CN1CCN(CC1)C(C)=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C17H20N4O2/c1-13(22)21-8-6-20(7-9-21)12-17(23)19-16-11-18-10-14-4-2-3-5-15(14)16/h2-5,10-11H,6-9,12H2,1H3,(H,19,23) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(4-acetylpiperazin-1-yl)-N-(isoquinolin-4-yl)acetamide |
|
| 8LJ | Name: | (2S)-2,3-dihydro-1H-pyrrole-2-carboxylic acid | Formula: | C5 H7 N O2 | SMILES: | C(=O)(O)C1NC=CC1 | InChi: | InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h1,3-4,6H,2H2,(H,7,8)/t4-/m0/s1 | Definition date: | 2017-02-13 | Last modified: | 2023-11-03 | Release date: | 2018-02-14 | Identifier: | (2S)-2,3-dihydro-1H-pyrrole-2-carboxylic acid |
|